Small Molecules

14 Mar 2007 Active Biotech's I-3D micro-dosing clinical trial concluded
14 Mar 2007 Nektar Initiates Phase 1 Clinical Program Evaluating NKTR-102 (PEG-irinotecan) for Potential to Treat Patients with Refractory Solid Tumors
14 Mar 2007 Cellzome Receives First Milestone Payment for Alzheimer's Program From Ortho-McNeil Pharmaceutical, Inc
14 Mar 2007 Array BioPharma and VentiRx Pharmaceuticals Announce License Agreement
14 Mar 2007 Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
14 Mar 2007 Obecure Initiates Phase II Weight Gain Prevention Study for Patients Taking Zyprexa
14 Mar 2007 Memory Pharmaceuticals Commences Phase 2a Trial of MEM 3454 in Alzheimer's Disease
13 Mar 2007 TorreyPines Therapeutics Initiates Phase I Multiple Dose Clinical Trial of NGX267, A Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
13 Mar 2007 Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy
13 Mar 2007 Depomed Files Investigational New Drug Application For Gabapentin Gr For The Treatment Of Postmenopausal Hot Flashes
13 Mar 2007 New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
13 Mar 2007 Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified Which Prevent Clear Interpretation of Results
10 Mar 2007 SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
10 Mar 2007 Positive Clinical Data for TASQ - Active Biotech's Novel Treatment of Prostate Cancer
09 Mar 2007 Second lung cancer trial adds to positive data on AS1404
09 Mar 2007 Depomed Completes Patient Enrollment In Phase 3 Clinical Trial Of Gabapentin Gr In Postherpetic Neuralgia
09 Mar 2007 Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer
08 Mar 2007 Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
08 Mar 2007 Stemline Expands its Oncology Pipeline with Acquisition of Clinically Active Compound Directed to "Cancer Stem Cell" Target
08 Mar 2007 NeuroSearch's license partner Abbott initiates clinical Phase II study with ABT-894 in Attention Deficit Hyperactivity Disorder (ADHD)
08 Mar 2007 Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5
08 Mar 2007 Bentley Announces Approval of Its First Generic Oncology Product in Spain
07 Mar 2007 Tekturna(R) - the first new type of high blood pressure medicine in more than a decade - receives its first approval in the US
07 Mar 2007 Swedish Osteoporosis Drug Begins Trials In Humans
07 Mar 2007 POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing